Tumor Imaging: Role of the Target Antigen

  • S. Matzku
  • W. Tilgen
  • H. Bihl
  • K. Schwechheimer
  • H. Kalthoff
  • W. Schmiegel
Conference paper

Summary

Tumor localization with monoclonal antibodies (MAbs) is fairly successful when MAbs are recognizing glycoconjugates, epitopes being variably associated with different types of surface molecules and with high molecular weight secretory products, especially mucins. It appears that extracellular pools of antigen in tumor tissue with remnants of epithelial organization offer particularly favourable conditions for MAb access. The problem of access has been adressed by using a new monoclonal anti-mucin antibody (RA-96), which shows excellent targeting properties to tissular deposits, although the target epitope is not detectable at the surface of tumor cells.

Keywords

Carbohydrate Adenocarcinoma Oncol Stratification Exter 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beatty JD, Duda RB, Williams LE et al (1986) Preoperative ima-ging of colorectal carcinoma with 111In-labeled antivcar-cinoembryonic antigen antibody. Cancer Res 46: 6494–6502PubMedGoogle Scholar
  2. Buraggi GL (1986) Radioimmunodetection of malignant melanoma with the 225.28S monoclonal antibody to HMW-MAA. Nucl Med 25: 220–224Google Scholar
  3. Chatal J-F, Saccavin J-C, Fumoleau P et al. (1984) Immunoscintigraphy of colon carcinoma. J Nucl Med 25: 307–314PubMedGoogle Scholar
  4. Colcher D, Horan Hand P, Nuti M, Schlom J (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc natl Acad SCi USA 78: 3199–3203PubMedCrossRefGoogle Scholar
  5. Dippold WG, Lloyd KO, Li LTC, Ikeda H, Oettgen HF, Old LJ (1980) Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA 77: 6114–6118Google Scholar
  6. Epenetos AA, Nimmon CC, Arklie J, Elliott AT, Hawkins LA, Knowles RW, Britton KE, Bodmer WF (1982) Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies. Br J Cancer 46: 1–8PubMedCrossRefGoogle Scholar
  7. Epenetos AA, Britton KE, Mather S, Shepherd J, Granowska M, Taylor-Papadimitriou J, Nimmon CC, Durbin H, Hawkins LA, Malpas JS, Bodmer WF (1982) Targeting of Iodine-123–1abelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet 999–1004Google Scholar
  8. Epenetos AA, Snook D, Durbin H, Johnson PM, Taylor-Papadimitriou J (1986) Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res 46: 3183–3191PubMedGoogle Scholar
  9. Esteban, JM, Colcher D, Sugarbaker P, Carrasquillo JA, Bryant G, Thor A, Reynolds JC, Larson SM, Schlom J (1987) Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3. Int J Cancer 39: 50–59PubMedCrossRefGoogle Scholar
  10. Gold P, Freedman SO (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467–481PubMedCrossRefGoogle Scholar
  11. Goldenberg DM, DeLand F, Kim E, Bennett S, Primus FJ, van Nagell JR, Estes N, DeSimone P, Rayburn P (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298: 1384–1388PubMedCrossRefGoogle Scholar
  12. Granowska M, Britton KE, Shepherd JH, Nimmon CC, Mather S, Ward B, Osborn RJ, Slevin ML (1986) A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer. J Clin Oncol 4: 730–736PubMedGoogle Scholar
  13. Griffiths AB, Burchel J, Gendler S, Lewis A, Blight K, Tilly R, Taylor-Papadimitriou J (1987) Immunological analysis of mucin molecules expressed by normal and malignant epithelial cells. Int J Cancer 40: 319–327PubMedCrossRefGoogle Scholar
  14. Koprowski H, Steplewski Z, Mitchell K et al. (1979) Colorectal carcinoma antigens detected by hybridoma antibodies Somatic Cell Genet 5: 957–972Google Scholar
  15. Lewis JCM, Boxer GM, Searle F et al. (1984) The comparative distribution of monoclonal antibodies to CEA in colorectal xenografts. Tumour Biol 5: 255–261PubMedGoogle Scholar
  16. Mach J-P, Carrel S, Merenda C et al (1974) In vivo localization of radiolabeled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248: 704–706PubMedCrossRefGoogle Scholar
  17. Mach J-P, Carrel S, Forni M et al. (1980) Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 303: 5–10PubMedCrossRefGoogle Scholar
  18. Mach J-P, Bischof-Delaloye A, Curchod S et al. (1987)L’immunoscintigraphie par les anticorps monoclonaux radiomarque’s. Schweiz med Wschr 117:1076–1086Google Scholar
  19. Magnani JL, Steplewski Z, Koprowski H et al. (1983) Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19–9 in the sera of patients as mucin. Cancer Res 43: 5489–5492PubMedGoogle Scholar
  20. Miotti S, Aguanno S, Canevari S, Diotti A, Orlandi R, Sonnino S, Colnaghi MI (1985) Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies. Cancer Res 45: 826–832PubMedGoogle Scholar
  21. Moshakis V, Ormerod MG, Westwood JH et al (1982) The site of binding of anti-CEA antibodies to tumour CEA in vivo: An immunochemical and autoradiographic approach. Br J Cancer 46: 18–21Google Scholar
  22. Pateisky N, Philipp K, Skodler WD, Czerwenka K, Hamilton G, Burchell J (1985) Radioimmunodetection in patients with suspected ovarian cancer. J Nucl Med 26: 1369–1376PubMedGoogle Scholar
  23. Pressman D (1980) The development and use of radiolabeled antitumor antibodies. Cancer Res 40: 2960–2964PubMedGoogle Scholar
  24. Rainsbury RM, Ott RJ, Westwood JH, Kalirai TS, Coombes RC, McCready VR, Neville AM, Gazet J-C (1983) Location of etastatic breast carcinoma by a monoclonal antibody chelate labelled with Indium-111. Lancet ii: 934–938Google Scholar
  25. Reading CL, Hutchins JT (1985) Carbohydrate structure in tumor immunity. Cancer Met Rev 4: 221–260CrossRefGoogle Scholar
  26. Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF (1981) Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture. Int J Cancer 28: 17–21Google Scholar
  27. Ward BG, Wallace K (1987) Lokalization of the monoclonal antibody HMFG2 after intravenous and intraperitoneal injection into nude mice bearing subcutaneous and intraperitoneal human ovarian cancer xenografts. Cancer Res 47: 4714–4718PubMedGoogle Scholar
  28. Ward BG, Mather SJ, Hawkins LR, Crowther ME, Shepherd JH, Granowska M, Britton KE, Slevin M (1987) Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: Assessment of intravenous and intraperitoneal routes of administration. Cancer Res 47: 4719–4723Google Scholar
  29. Wilson BS, Ruberto G, Ferrone S (1983) Immunochemical characterization of a human high molecular weight-melanoma associated antigen identified with monoclonal antibodies. Cancer Immunol Immunother 14: 196–201PubMedCrossRefGoogle Scholar
  30. Wilson BS, Imai K, Natali PG, Bigotti A, Cavaliere R, Pellegrino MA, Ferrone S (1981) Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer 28: 293–300PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • S. Matzku
    • 1
  • W. Tilgen
    • 2
  • H. Bihl
    • 2
  • K. Schwechheimer
    • 2
  • H. Kalthoff
    • 3
  • W. Schmiegel
    • 3
  1. 1.Institut für NuklearmedizinDeutsches KrebsforschungszentrumHeidelbergGermany
  2. 2.University of HeidelbergGermany
  3. 3.University of HamburgGermany

Personalised recommendations